Resmed Inc banner

Resmed Inc
F:RMEA

Watchlist Manager
Resmed Inc Logo
Resmed Inc
F:RMEA
Watchlist
Price: 18.8 EUR 0.53% Market Closed
Market Cap: €27.7B

Wall St Price Targets

RMEA Price Targets Summary
Resmed Inc

Wall Street analysts forecast RMEA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RMEA is 22.73 EUR with a low forecast of 16.3 EUR and a high forecast of 30.59 EUR.

Lowest Forecast
Price Target
16.3 EUR
13% Downside
Average Forecast
Price Target
22.73 EUR
21% Upside
Highest Forecast
Price Target
30.59 EUR
63% Upside
Resmed Inc Competitors:
Price Targets
VIBHA
Vibhavadi Medical Center PCL
6% Upside

Revenue
Forecast

11% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 8%.

Gross Profit
Forecast

11% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
11% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 4 years is 10%.

Operating Income
Forecast

14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 4 years is 11%.

Pre-Tax Income
Forecast

13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 13%.

Net Income
Forecast

14% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
14% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 4 years is 10%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RMEA's stock price target?
Price Target
22.73 EUR

According to Wall Street analysts, the average 1-year price target for RMEA is 22.73 EUR with a low forecast of 16.3 EUR and a high forecast of 30.59 EUR.

What is the Revenue forecast for Resmed Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 8%.

What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 4 years is 10%.

What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 4 years is 11%.

What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 13%.

What is the Net Income forecast for Resmed Inc?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 4 years is 10%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett